Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study von Cohen, Ezra E W, Soulières, Denis, Le Tourneau, Christophe, Dinis, José, Licitra, Lisa, Ahn, Myung-Ju, Soria, Ainara, Mach, Nicolas, Mehra, Ranee, Burtness, Barbara, Zhang, Pingye, Cheng, Jonathan, Swaby, Ramona F, Acosta-Rivera, Mirelis, Adkins, Douglas R., Aghmesheh, Morteza, Ahn, Myung-Ju, Airoldi, Mario, Aleknavicius, Eduardas, Al-Farhat, Yousuf, Algazi, Alain P., Almokadem, Salah, Alyasova, Anna, Bauman, Jessica R., Benasso, Marco, Berrocal, Alfonso, Bray, Victoria, Burtness, Barbara Ann, Caponigro, Francesco, Castro, Ana, Cescon, Terrence P., Chan, Kelvin, Chaudhry, Arvind, Chauffert, Bruno, Cohen, Ezra, De Boer, J.P., Dietz, Andreas, Dinis, Jose, Dupuis, Charlotte, Digue, Laurence, Escobar Alvarez, Yolanda, Evans, Mererid, Fidler, Mary Jo, Forster, Martin David, Friesland, Signe, Ganti, Apar K., Geoffrois, Lionnel, Grant, Cliona, Gruenwald, Viktor, Harrington, Kevin, Horvai, Geza, Inciura, Arturas, Jang, Raymond, Jankowska, Petra, Jimeno, Antonio, Joseph, Mano, Juarez Ramiro, Alejandro, Karaszewska, Boguslawa, Kawecki, Andrzej, Keilholz, Ulrich, Keller, Ulrich, Kocsis, Judit, Kotecki, Nuria, Kozloff, Mark F., Lambea, Julio, Landherr, Laszlo, Lantsukhay, Yuri, Lazarev, Sergey Alexandrovich, Lee, Lip Way, Le Tourneau, Christophe, Licitra, Lisa, Martincic, Danko, Matorin, Oleg Vladmirovhich, McGrath, Margaret, Machiels, Jean-Pascal, Mehra, Ranee, Misiukiewicz, Krzysztof, Morris, John C., Mufazalov, Fagim Fanisovich, Niu, Jiaxin, Pamoorthy Srinivasan, Devraj, Perez Segura, Pedro, Rauch, Daniel, Ribeiro, Maria Leonor, Rodriguez, Cristina, Rolland, Frederic, Russo, Antonio, Ruzsa, Agnes, Sanches, Frederico, Shin, Sang-Won, Shtiveland, Mikhail, Soulieres, Denis, Specenier, Pol, van Herpen, Carla M.L., Velez-Cortes, Hector A., Walsh, William V., Winterhalder, Ralph, Wojtukiewicz, Marek, Wong, Deborah, Zandberg, Dan

Volltext

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) von Burtness, B., Harrington, K.J., Greil, R., Soulières, D., Tahara, M., De Castro, G., Psyrri, A., Baste Rotllan, N., Neupane, P.C., Bratland, Å, Fuereder, T., Hughes, B.G.M., Mesia, R., Ngamphaiboon, N., Rordorf, T., Wan Ishak, W.Z., Roy, A., Cheng, J., Jin, F., Rischin, D.

Volltext

Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma von Delea, T E, Khuu, A, Heng, D YC, Haas, T, Soulières, D

Volltext

Pembrolizumab for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of treatment options from the phase III KEYNOTE-040 trial von Le Tourneau, C., Cohen, E.E.W., Harrington, K.J., Dinis, J., Licitra, L., Ahn, M.-J., Soria, A., Machiels, J.-P., Mach, N., Mehra, R., Burtness, B., Zhang, P., Cheng, J., Swaby, R., Soulières, D.

Volltext

A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck von Abdul Razak, A.R., Soulières, D., Laurie, S.A., Hotte, S.J., Singh, S., Winquist, E., Chia, S., Le Tourneau, C., Nguyen-Tan, P.- F., Chen, E.X., Chan, K.K., Wang, T., Giri, N., Mormont, C., Quinn, S., Siu, L.L.

Volltext

ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro von Amrein, L, Rachid, Z, Jean-Claude, B, Soulières, D, Aloyz, R, Panasci, L

Volltext

OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN von Soulières, D, Faivre, S, Mesía, R, Remenár, E, Li, S.H, Karpenko, A, Dechaphunkul, A, Keilholz, U, Kiss, L, Lin, J.C, Nagarkar, R, Tamás, L, Kim, S.B, Erfán, J, Alyasova, A, Yovine, A, Le Mouhaër, S, Solovieff, N, Turri, S, Licitra, L

Volltext

Phase 1-2 Study Evaluating Reduced Radiation Volume and Dosage Using Comprehensive Tomotherapy and Concurrent Chemotherapy for Oropharyngeal Carcinoma von Alizadeh-Kashani, M, Lambert, L, Édith, F, Guertin, L, Fortin, I, Soulières, D, Manon, B, Nguyen-Tan, P

Volltext

Review of guidelines on the treatment of metastatic renal cell carcinoma von Soulières, D

Volltext

KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies von Soulières, D, Greer, W, Magliocco, Anthony M, Huntsman, D, Young, S, Tsao, M-S, Kamel-Reid, S

Volltext

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease r... von Harrington, K.J., Cohen, E.E.W., Soulières, D., Dinis, J., Licitra, L., Ahn, M.-J., Soria, A., Machiels, J.-P., Mach, N., Mehra, R., Burtness, B., Swaby, R.F., Lin, J., Ge, J., Lerman, N., Tourneau, C. Le

Volltext

The Role of PET-CT After Chemoradiation in Partially Regressed Nodal Disease von Alizadeh-Kashani, M, Lambert, L, Guertin, L, Belair, M, Christopoulos, A, Soulières, D, Filion, E

Volltext

PO-126: Adaptive Radiation Therapy in HPV Positive Oropharyngeal Carcinoma: A Preliminary Toxicity Report von Alizadeh, M, Lambert, L, Filion, E, Guertin, L, Fortin, I, Soulières, D, Bélair, M, Nguyen-Tan, F.P

Volltext

A Comparison of Simultaneously Integrated Boost using Intensity-modulated Radiation Therapy and Conventional Radiation Therapy in the Setting of Concomitant Carboplatin and 5-Fluor... von Clavel, S, Nguyen, D.H.A, Fortin, B, Després, P, Donath, D, Coulombe, G, Soulières, D, Charpentier, D, Guertin, L, Nguyen-Tan, F

Volltext

Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting von Nazha, S, Tanguay, S, Kapoor, A, Jewett, M, Kollmannsberger, C, Wood, L, Bjarnason, G, Heng, D, Soulières, D, Reaume, N, Basappa, N, Lévesque, E, Dragomir, A

Volltext

Dynamic Prediction of Toxicities in Head and Neck Cancer Radiotherapy by 3D Convolutional Neural Network Using Daily Cone-Beam CTs von Bang, C., Le, W., Nguyen-Tan, P.F., Filion, E., Soulières, D., O'Sullivan, B., Christopoulos, A., Bissada, E., Ayad, T., Guertin, L., Lalonde, A., Markel, D., Kadoury, S., Bahig, H.

Volltext

Stereotactic Boost and Short-Course Radiotherapy for p16-Associated Oropharynx Cancer (SHORT-OPC): First Planned Interim Safety Analysis from a Randomized Phase II Trial von Bahig, H., Nguyen-Tan, P.F., Yuan, Y., Filion, E., Ng, S.P., Soulières, D., Christopoulos, A., Fuller, C.D., Garden, A.S., Hutcheson, K.A., Lee, A., Spiotto, M.T., Rosenthal, D.I., Phan, J.

Volltext

HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience von Thibaudeau, Ève, Fortin, Bernard, Coutlée, F., Nguyen-Tan, Phuc Félix, Weng, Xiaoduan, Audet, Marie-Lise, Abboud, O., Guertin, Louis, Christopoulos, A., Tabet, Jean-Claude, Soulières, Denis

Volltext

Renal cell carcinoma in the Canadian Indigenous population von Wong, E C L, Breau, R H, Mallick, R, Wood, L, Pouliot, F, Basappa, N S, Tanguay, S, Soulières, D, So, A, Heng, D, Lavallée, L T, Drachenberg, D, Kapoor, A

Volltext

Is Concurrent Chemotherapy and Radiotherapy in Elderly Head and Neck Patients a Reasonable and Safe Approach? The Notre-Dame Hospital Experience von Mehiri, S, Clavel, S, Fortin, B, Després, P, Coulombe, G, Donath, D, Guertin, L, Soulières, D, Charpentier, D, Nguyen-Tan, P

Volltext